zd 7288 has been researched along with Migraine Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X; Mai, J; Xie, H; Yang, L; Zeng, X | 1 |
| Eroli, F; Nistri, A; van den Maagdenberg, AMJM; Vilotti, S | 1 |
2 other study(ies) available for zd 7288 and Migraine Disorders
| Article | Year |
|---|---|
Activation of CB1R alleviates central sensitization by regulating HCN2-pNR2B signaling in a chronic migraine rat model.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Central Nervous System Sensitization; Hyperalgesia; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Male; Migraine Disorders; Potassium Channels; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Receptors, N-Methyl-D-Aspartate | 2023 |
Hyperpolarization-activated current I
Topics: Action Potentials; Animals; Cerebellar Ataxia; Disease Models, Animal; Gene Knock-In Techniques; Membrane Potentials; Mice, Transgenic; Migraine Disorders; Pyrimidines; Receptors, Purinergic P2X3; Sensory Receptor Cells; Trigeminal Ganglion | 2017 |